Vaccine-preventable diseases: The role of the European Centre for Disease Prevention and Control

Clinical Microbiology and Infection

Volumn 20, Issue S5, 2014, Pages 2-6

  Kramarz, P ^a   Lopalco, P L ^a   Huitric, E ^a   Pastore Celentano, L ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Epidemiology; European Union; Vaccination programmes; Vaccine preventable diseases

Indexed keywords

DISEASE SURVEILLANCE; EUROPEAN UNION; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; PREVENTION AND CONTROL; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PREVENTABLE DISEASE AND INVASIVE BACTERIAL INFECTION PROGRAM; INFECTION CONTROL; MEDICAL SOCIETY; PUBLIC HEALTH;

BACTERIA (MICROORGANISMS);

VACCINE;

COMMUNICABLE DISEASE CONTROL; EUROPEAN UNION; HUMANS; PUBLIC HEALTH; SOCIETIES, MEDICAL; VACCINATION; VACCINES;

EID: 84897554060     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12430     Document Type: Review

References (33)

1. Regulation (EC) No 851/2004 of the European parliament and of the council of 21 April 2004 establishing a European centre for disease prevention and control 2004 [accessed 10 Sep 2013]. Available from: http://ecdc.europa.eu/en/aboutus/key%20documents/0404_kd_regulation_establishing_ecdc.pdf.
2. ECDC. Disease programmes. Stockholm: ECDC, 2013 [accessed 10 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/activities/diseaseprogrammes/Pages/Activities_DiseaseProgrammes.aspx.
3. ECDC. Vaccine-preventable diseases 2013 [accessed 10 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/activities/diseaseprogrammes/vpd/Pages/index.aspx.
4. ECDC. Surveillance of communicable diseases in the European Union. A long-term strategy: 2008-2013. 2008 [Accessed 18 Sep 2013] available from: http://www.ecdc.europa.eu/en/aboutus/key%20documents/08-13_kd_surveillance_of_cd.pdf.
5. ECDC. External quality assurance scheme for Streptococcus pneumoniae-2012. Stockholm: ECDC, 2013. [Accessed 17 Sep 2013]. Available from: http://ecdc.europa.eu/en/publications/Publications/streptococcus-pneumoniae-EQA-2012.pdf
6. ECDC. External quality assurance scheme for Haemophilus influenzae-2011. Stockholm: ECDC, 2013 [Accessed 17 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/EQA-haemophilus-influenzae-2012.pdf.
7. ECDC. External quality assessment scheme 2011 for Neisseria meningitidis Stockholm. Stockholm: ECDC, 2013 [Accessed 17 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/External%20quality%20assessment%20scheme%202012%20for%20Neisseria%20meningitidis%20-%20web.pdf.
8. ECDC. External quality assurance scheme for diphtheria diagnostics 2012. Stockholm: ECDC, 2013 [Accessed 17 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/publications/publications/diphtheria-external-quality-assessment-2012.pdf.
9. ECDC. Measles and rubella monitoring 2013 [accessed 17 Sep 2013]. Available from: http://ecdc.europa.eu/en/publications/Publications/Measles-rubella-monitoring_June_2013.pdf.
10. ECDC. External quality assurance scheme on PCR for Bordetella pertussis, 2012. On behalf of the EUpert-labnet network ECDC, 2012.
11. ECDC. Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis. Stockholm: ECDC, 2012.
12. ECDC. Guidance and protocol for the use of realtime PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis. Stockholm: ECDC, 2012 [Accessed 17 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Guidance-protocol-PCR-laboratory-diagnosis-bordatella-pertussis-parapertussis.pdf.
13. Vaccine European New Integrated Collaboration Effort (VENICE II) project. 2013. [accessed 14 Sep 2013]. Available from: http://venice.cineca.org/.
14. WHO Regional office for Europe: CISID database 2013 [accessed 2013 1 Oct]. Available from: http://data.euro.who.int/cisid/.
15. ECDC founding regulation 2013 [accessed 16 Sep 2013]. Available from: http://ecdc.europa.eu/en/aboutus/key%20documents/0404_kd_regulation_establishing_ecdc.pdf.
16. Helena de Carvalho Gomes E. IRIS prioritisation tool 2013 [accessed 16 Sep 2013]. Available from: http://colloquium.cochrane.org/fr/abstracts/iris-%E2%80%93-tool-prioritising-guidance-development-european-centre-disease-prevention-and-contr.
17. ECDC. ECDC expert directory 2013 [accessed 16 Sep 2013]. Available from: http://ecdc.europa.eu/en/aboutus/external_experts/Pages/external_experts.aspx.
18. ECDC. ECDC guidance 2013 [accessed 16 Sep 2013]. Available from: http://www.ecdc.europa.eu/en/publications/guidance/Pages/index.aspx.
19. ECDC. Introduction of HPV vaccines in EU countries-an update. Stockholm: ECDC, 2012.
20. ECDC. EWRS 2013 [accessed 16 Sep 2013]. Available from: https://ewrs.ecdc.europa.eu/.
21. ECDC. EPIS 2013 [accessed 16 Sep 2013]. Available from: http://ecdc.europa.eu/en/activities/epidemicintelligence/pages/epidemicintelligence_tools.aspx.
22. Dieleman J, Lecomte C, Schuemie M, Van Rolleghem RA, Hviid A, Svanstrom H, et al. Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe. Pharmacoepidemiol Drug Saf 2011; 20: S260-S.
23. Andrews N, Stowe J, Miller E, Svanstrom H, Johansen K, Bonhoeffer J, et al. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine 2012; 30: 3042-3046. PubMed PMID: 21699947.
24. Dieleman JP, Romio SS, de Vries VC, Sammon CJ, Andrews N, Hviid A, et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines-a multinational case-control study in Europe. Pharmacoepidemiol Drug Saf 2011; 20: S258-S259.
25. Weibel D, Romio S, Dieleman JP, de Vries VC, Sammon C, Andrews N, et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational self controlled case series study in Europe. Pharmacoepidemiol Drug Saf 2012; 21: 354-355.
26. ECDC. Eurovaccine 2013 [accessed 17 Sep 2013]. Available from: https://twitter.com/Eurovaccine.
27. Hofstetter AM, Rosenthal SL. Health care professional communication about STI vaccines with adolescents and parents. Vaccine 2013; http://dx.doi.org/10.1016/j.vaccine.2013.06.035 PubMed PMID: 23791695.
28. ECDC. Communication on immunisation-building trust. Stockholm, 2012. [accessed 17 Sep 2013]. Available from: http://ecdc.europa.eu/en/publications/publications/ter-immunisation-and-trust.pdf.
29. ECDC. Measles atlas 2013 [accessed 17 Sep 2013]. Available from: http://emmageocase.ecdc.europa.eu/atlas/measles/.
30. ECDC. The message 2013 [accessed 17 Sep 2013]. Available from: http://venice.cineca.org/register.php.
31. WHO Regional Office for Europe. Surveillance guidelines for measles, rubella and congenital rubella syndrome in the WHO European region-update December 2012. Copenhagen: WHO EURO, 2012.
32. ECDC. Let's talk about protection [accessed 2013 Oct]. Available from: http://ecdc.europa.eu/en/healthtopics/immunisation/comms-aid/Pages/protection.aspx.
33. ECDC. Vaccine scheduler 2013 [accessed 17 Sep 2013]. Available from: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx.